胡红耀
放射
放射介入科主任；主任医师，硕士生导师
放射介入科主任；主任医师，硕士生导师
导师介绍
| 姓名 | 胡红耀 |
| 出生年月 | 1968年2月 |
| 单位 | 武汉大学人民医院介入科 |
| 所属学科 | 临床医学-医学影像学 介入放射学 |
| 职务、职称及头衔 | 放射介入科主任；主任医师，硕士生导师 |
| huhongyao@vip.163.com | |
| 联系方式 | 13971319787 |
| 研究方向 |
1.血管性疾病的发生机制和干预方法 2.肿瘤介入治疗的基础与临床研究 |
| 个人简介 | |
|
从事放射诊断、放射介入临床、教学、科研工作30余年，在放射介入临床和学科建设方面有突出贡献。省内率先开展缺血性脑血管病的介入治疗；下肢动脉硬化闭塞症及内脏血管病介入、透析通路失功的介入、肝癌的综合介入、复杂主骼动脉闭塞杂交手术、肠系膜上动脉夹层急诊介入及杂交处理、ＶＴＥ防治及危重症ＰＥ综合介入治疗等达国内先进水平；胸腹主动脉夹层及动脉瘤的介入治疗达省内领先水平。 主要科学研究方向为血管性疾病的发生机制和干预方法、肿瘤介入治疗的基础与临床研究。先后开展缺血缺氧及高糖状态下心脏、血管疾病发病机及其干预研究；CTRP9血管保护作用及机制；内皮细胞炎症反应对外周动脉疾病影响和机制。开展了外周动静脉血栓栓塞治疗临床研究。主持湖北省自然科学基金２项，参与省重大项目及相关介入器械药物临床前研究10余项，项目经费100余万元。以第一和/或通知作者发表SCI论文4篇，中华或中文核心期刊论文30余篇。 开展各学制本科生及研究生理论教学和临床带教，先后参与培养研究生20余名，培养专科进修医师100余名，其中多余名已成长为我省血管介入领域学科带头人和主要骨干。 |
|
| 学术任职与荣誉 | |
|
学术任职 1.中国医师协会介入医师分会外周血管专业委员会委 2.中国介入医师协会大血管专委会委员 3.中国抗癌协会肿瘤介入学专业委员会委员 4.中华医学会心血管病分会大血管学组委员 5. 中国研究型医院学会出血专业委员会委员 6. 中华医学会放射学分会介入学组委员 7. 中国医学装备学会普通放射装备委员会DSA学组委员 8. 中国中西医结合学会第一届介入专业委员会副主任委员 9. 国际静脉联盟中国静脉分会委员 10. 中南地区介入治疗协作组理事 11. 湖北省医学会介入医学分会主任委员 12. 湖北省抗癌协会肿瘤介入学专业委员会副主任委员 13. 湖北省医学会血管外科分会委员 14. 武汉市放射学会委员 15. 《中国介入影像与治疗学》编委 16. 《肿瘤防治研究》编委 17. 《中华介入放射学电子杂志》编委 社会任职 1. 卫计委医疗服务标准专业委员会专家库专家 2. 卫计委医疗设备专家库专家 3. 湖北省卫健委放射医学质量控制中心专家委员会委 4. 湖北省放射介入质量控制专家成员 5. 湖北省大型医用设备管理专家 6. 医疗器械技术审评中心外聘专家 |
|
| 教育履历 | |
|
1986.09-1991.07 湖北医学院，医疗系，学士学位 2000.09-2004.07 武汉大学，社会医学与卫生事业管理，硕士学位 2005.07-2012.11 武汉大学，内科学，博士学位 2000.08-2001.01 北京大学第一医院介入专业培训进修 先后赴德国莱比锡大学血管介入中心、美国凤凰城心血管医院交流学习 |
|
| 工作履历 | |
|
1991.07-1996.10 武汉大学人民医院放射科住院医师 1996.10-2001.10 武汉大学人民医院放射科副主任，主治医师 2001.10-2013.03 武汉大学人民医院放射科副主任，副主任医师 2013.03-2019.04 武汉大学人民医院放射科副主任、放射介入科主任，副主任医师 2019.04-2020.10 武汉大学人民医院放射介入科主任，副主任医师 2020.10-现在 武汉大学人民医院放射介入科主任，主任医师、硕士生导师 |
|
| 成果获奖 | |
| 无 | |
| 代表性论著 | |
|
1.Li S, Wang XJ, Hu HY, et al. Additional Value
of Non-contrast Chest CT in the Prediction of Adverse Cardiovascular Events
in Patients With Novel Coronavirus Disease 2019 (COVID-19). Front Cardiovasc
Med, 2021 Oct 15；8:738044. (IF: 5.846，SCI二区)共同第一作者 2.Chen CY, Qiu HM, Yao YH, et al. Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.Clinics and Research in Hepatology and Gastroenterology,2021，45（2）101460.March2021,https://doi.org/10.1016/j.clinre.2020.05.008（IF: 3.189，SCI三区）共同通讯 3.Hu HY*, Li W#, Liu MX, Xiong JR, Wei YZ, Zhao H, Wu ZZ, Rao M, Tang YH, Huang CX. C1q/TNF-related protein-9 attenuates diabetic nephropathy and kidney fibrosis in db/db mice. DNA and Cell Biology,2020,39(6):938-9482020 June. (IF: 3.550,SCI二区)通讯作者 4.胡红耀*，赵辉，吴振中，饶珉.藤黄酸对心肌梗死大鼠心功能的影响及其机制,武汉大学学报（医学版）2020，41(2):188-192通讯作者 5.赵辉，胡红耀*，饶珉，吴振中，任权，吴晶晶，李忠.经皮机械性血栓清除术治疗急性髂股静脉血栓,中国介入影像与治疗学，2020,17(7):393-397通讯作者 6.赵辉，胡红耀*，饶珉，吴振中，任权，吴晶晶，王英，冯军伟. Rotarex机械血栓清除术治疗股腘动脉血栓所致急性下肢缺血.中国介入影像与治疗学，2020,17(8):449-453通讯作者 7.Hu HY*, Li L, Yu TH, Li YJ, Tang YH. Interleukin-22 receptor 1 upregulation and activation in hypoxic endothelial cells improves perfusion recovery in experimental peripheral arterial disease. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018,505(1):60-66（IF：3.322,SCI三区)第一兼通讯作者 8.胡红耀,鲁志兵,崔博,何勃,胡笑容,吴柳,黄从新,江洪*.迷走神经介导性心房颤动和六小时快速起搏介导性心房颤动的回复性质研究.中华心律失常学杂志，2012,16（1）：61-66 9.胡红耀,袁明杰,黄鹤,唐艳红,吴钢,顾永伟,陈勇军,黄从新,江洪*.Ghrelin对大鼠心肌梗死后电重构中的影响.中华心律失常学杂志，2012,16（5）：135-138 |
| Name | Hu Hongyao |
| Date of birth | February,1968 |
| Department | Department of Interventional Radiology, Renmin Hospital of Wuhan University |
| Title | Director of Department of Intervention Radiology， Chief physician， Master tutor |
| huhongyao@vip.163.com | |
| TEL | 13971319787 |
| Research Direction | |
|
1.Mechanisms and interventions of vascular
diseases 2.Basic and clinical research of tumor interventional therapy |
|
| Personal Profile | |
|
Doctor Hu has been engaged in the clinical
medicine, education and scientific research of diagnostic radiology as well
as interventional radiology for more than 30 years. He has made outstanding
contributions in the clinic and discipline construction of interventional
radiology. Doctor Hu took the lead in the interventional therapy of ischemic
cerebrovascular diseases in Hubei Province. His ability has reached the
advanced level in China in field of interventional therapy including the
interventional therapy of lower extremity arteriosclerosis obliterans,
visceral vascular diseases and dialysis access dysfunction, the comprehensive
intervention of liver cancer, the hybrid therapy for complex aortoiliac
artery obliterans, emergency intervention and hybrid treatment of superior
mesenteric artery dissection, the prevention of VTE and comprehensive
interventional treatment of critical PE. The interventional treatment of
thoracoabdominal aortic dissection and aneurysm have reached the leading
level in the province. His main research directions include: the mechanism and intervention methods of vascular diseases, foundational and clinical study of tumor interventional therapy. Doctor Hu has successfully conducted a series of researches, such as explorations on the pathogenesis and intervention of cardiovascular diseases under ischemia-hypoxia and high glucose, the vascular protective effect and mechanism of CTRP9, the effect and mechanism of inflammatory response in the endothelial cell on peripheral artery disease. He is also doing clinical study on the treatment of peripheral arteriovenous thromboembolism. He has presided over two Natural Science Foundation of Hubei Province,and participated in more than 10 provincial major projects and related pre-clinical research of interventional devices and drugs. Besides, Doctor Hu has published 4 SCI papers and more than 30 papers in Chinese core journals as the first and/or corresponding author. He has carried out theoretical and clinical teaching for undergraduates and postgraduates, and has trained more than 20 postgraduates and more than 100 specialists, many of whom have become the discipline leaders and the mainstay in the field of vascular intervention in Hubei Province. |
|
| Selected Publications | |
|
1.Li S, Wang XJ, Hu HY*, et al. Additional Value
of Non-contrast Chest CT in the Prediction of Adverse Cardiovascular Events
in Patients With Novel Coronavirus Disease 2019 (COVID-19). Front Cardiovasc
Med, 2021 Oct 15；8:738044. (IF: 5.846，SCI Q2) (co-first author) 2.Chen CY, Qiu HM, Yao YH*, et al. Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.Clinics and Research in Hepatology and Gastroenterology,2021，45（2）101460.March 2021,https://doi.org/10.1016/j.clinre.2020.05.008 (IF:3.189，SCI Q3) (co-corresponding author) 3.Hu HY*, Li W#, Liu MX, Xiong JR, Wei YZ, Zhao H, Wu ZZ, Rao M, Tang YH, Huang CX. C1q/TNF-related protein-9 attenuates diabetic nephropathy and kidney fibrosis in db/db mice. DNA and Cell Biology,2020,39(6):938-9482020 June. (IF:3.550,SCI Q2) (corresponding author) 4.Hu HY*, Zhao H, Wu ZZ, Rao M. Effects of garcinoic acid on cardiac function and its mechanism in post-myocardial infarction rats. Medical Journal of Wuhan University, 2020，41(2):188-192 (corresponding author) 5.Zhao H, Hu HY*, Rao M, Wu ZZ, Ren Q, Wu JJ, Li Z. Percutaneous mechanical thrombectomy for treatment of acute iliofemoral vein thrombi. Chinese Journal of Interventional Imaging and Therapy, 2020,17(7):393-397 (corresponding author) 6.Zhao H, Hu HY*, Rao M, Wu ZZ, Ren Q, Wu JJ, Wang Y, Feng JW. Rotarex mechanical thrombectomy for treatment of acute limb ischemia caused by femoropopliteal artery thrombosis. Chinese Journal of Interventional Imaging and Therapy, 2020,17(8):449-453 (corresponding author) 7.Hu HY*, Li L, Yu TH, Li YJ, Tang YH. Interleukin-22 receptor 1 upregulation and activation in hypoxic endothelial cells improves perfusion recovery in experimental peripheral arterial disease. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018,505(1):60-66 (IF：3.322,SCI Q3) (first and corresponding author) 8.Hu HY*, Lu ZB, Cui B, He B, Hu XR, Wu L, Huang CX, Jiang H. Distinct restitution properties in vagally mediated atrial fibrillation and 6 h rapid pacing induced atrial fibrillation. Chinese Journal of Cardiac Arrhythmias, 2012,16（1）：61-66 9.Hu HY*, Yuan MJ, Huang H, Tang YH, Wu Gang, GU YW, Chen YJ, Huang CX, Jiang H. Effects of Ghrelin on electrical remodeling in rats with myocardial infarction. Chinese Journal of Cardiac Arrhythmias, 2012,16（5）：135-138 |
武汉大学人民医院
湖北省人民医院